These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

600 related articles for article (PubMed ID: 33510041)

  • 1. High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry.
    Marques CDL; Kakehasi AM; Pinheiro MM; Mota LMH; Albuquerque CP; Silva CR; Santos GPJ; Reis-Neto ET; Matos P; Devide G; Dantas A; Giorgi RD; Marinho AO; Valadares LDA; Melo AKG; Ribeiro FM; Ferreira GA; Santos FPS; Ribeiro SLE; Andrade NPB; Yazbek MA; Souza VA; Paiva ES; Azevedo VF; Freitas ABSB; Provenza JR; Toledo RA; Fontenelle S; Carneiro S; Xavier R; Pileggi GCS; Reis APMG
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33510041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
    Marques CDL; Ribeiro SLE; Albuquerque CP; de Sousa Studart SA; Ranzolin A; de Andrade NPB; Dantas AT; Mota GD; Resende GG; Marinho AO; Angelieri D; Andrade D; Ribeiro FM; Omura F; Silva NA; Rocha Junior L; Brito DE; Fernandino DC; Yazbek MA; Souza MPG; Ximenes AC; Martins ASS; Castro GRW; Oliveira LC; Freitas ABSB; Kakehasi AM; Gomides APM; Reis Neto ET; Pileggi GS; Ferreira GA; Mota LMH; Xavier RM; de Medeiros Pinheiro M;
    Adv Rheumatol; 2022 Nov; 62(1):45. PubMed ID: 36419163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Among Patients With Inflammatory Rheumatic Diseases.
    Esatoglu SN; Tascilar K; Babaoğlu H; Bes C; Yurttas B; Akar S; Pehlivan O; Akleylek C; Tecer D; Seyahi E; Yuce-Inel T; Alpay-Kanitez N; Bodakci E; Tekgoz E; Colak S; Bolek EC; Koca SS; Kalyoncu U; Icacan OC; Ugurlu S; Oz HE; Hamuryudan V; Hatemi G;
    Front Immunol; 2021; 12():651715. PubMed ID: 33936073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study.
    Marques C; Kakehasi AM; Gomides APM; Paiva EDS; Dos Reis Neto ET; Pileggi GCS; Provenza JR; Mota L; Xavier RM; Ferreira GA; Pinheiro MM
    JMIR Res Protoc; 2020 Dec; 9(12):e24357. PubMed ID: 33156812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network.
    Raiker R; Pakhchanian H; DeYoung C; Gupta L; Kardeş S; Ahmed S; Kavadichanda C
    J Autoimmun; 2021 Dec; 125():102730. PubMed ID: 34649723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of patients with COVID-19 admitted to ICU in a tertiary hospital in Stockholm, Sweden.
    Larsson E; Brattström O; Agvald-Öhman C; Grip J; Campoccia Jalde F; Strålin K; Nauclér P; Oldner A; Konrad D; Persson BP; Eriksson LI; Mårtensson J;
    Acta Anaesthesiol Scand; 2021 Jan; 65(1):76-81. PubMed ID: 32892337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry.
    Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ;
    Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology, outcomes, and the use of intensive care unit resources of critically ill patients diagnosed with COVID-19 in Sao Paulo, Brazil: A cohort study.
    Socolovithc RL; Fumis RRL; Tomazini BM; Pastore L; Galas FRBG; de Azevedo LCP; Costa ELV
    PLoS One; 2020; 15(12):e0243269. PubMed ID: 33270741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study.
    Nachtigall I; Lenga P; Jóźwiak K; Thürmann P; Meier-Hellmann A; Kuhlen R; Brederlau J; Bauer T; Tebbenjohanns J; Schwegmann K; Hauptmann M; Dengler J
    Clin Microbiol Infect; 2020 Dec; 26(12):1663-1669. PubMed ID: 32822883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
    FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
    Ann Rheum Dis; 2021 Apr; 80(4):527-538. PubMed ID: 33268442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV brasil registry.
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33563704
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors Associated With Mortality in Patients With Immune-Mediated Rheumatic Diseases and COVID-19 From Latin America: Data From Argentina, Mexico, and Brazil.
    Isnardi CA; Alpizar-Rodriguez D; Calderaro DC; Marques CDL; Pons-Estel GJ; Xavier RM; Saurit V; Pisoni CN; Tissera YS; D'Angelo Exeni ME; Alba P; Pereira D; Gobbi CA; Gamba MJ; Alfaro MA; Virasoro BM; Colunga-Pedraza IJ; Irazoque-Palazuelos F; Reyes-Cordero G; Rodriguez-Reyna TS; Veloz-Aranda JA; Skinner-Taylor CM; Juárez-Mora IM; Silveira LH; Pacheco Tena CF; Xibille-Friedmann DX; Ferreira GA; Kakehasi AM; Pinheiro MM; Gomides APM; Pileggi GCS; da Mota LMH; Dos Reis-Neto ET; Ribeiro SLE; de Azevedo Valadares LD; Martínez-Martínez MU
    J Clin Rheumatol; 2024 Jan; 30(1):e9-e17. PubMed ID: 37936271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
    Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
    Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of mortality in a large group of hemodialysis patients hospitalized for COVID-19.
    Turgutalp K; Ozturk S; Arici M; Eren N; Gorgulu N; Islam M; Uzun S; Sakaci T; Aydin Z; Sengul E; Demirelli B; Ayar Y; Altiparmak MR; Sipahi S; Mentes IB; Ozler TE; Oguz EG; Huddam B; Hur E; Kazancioglu R; Gungor O; Tokgoz B; Tonbul HZ; Yildiz A; Sezer S; Odabas AR; Ates K
    BMC Nephrol; 2021 Jan; 22(1):29. PubMed ID: 33446135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with poor outcomes in SLE patients with COVID-19: Data from
    Carvalho JS; Dos Reis Neto ET; Kakehasi AM; Ribeiro SL; Studart SA; Martins FP; Cavalheiro do Espírito Santo R; Ranzolin A; Fernandino DC; Dinis VG; Sato EI; Resende GG; Marinho A; Mariz HA; Sacilotto NC; Ribeiro FM; Shinjo SK; Dias LH; Yazbek MA; Omura F; Rached TH; Gomides APM; Marques CD; Pillegi GC; Mota LM; Pinheiro MM; Monticielo OA; Xavier RM; Ferreira GA;
    Lupus; 2023 Jan; 32(1):42-53. PubMed ID: 36300790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of acute deterioration and care complexity individual factors associated with health outcomes in hospitalised patients with COVID-19: a multicentre cohort study.
    Adamuz J; González-Samartino M; Jiménez-Martínez E; Tapia-Pérez M; López-Jiménez MM; Rodríguez-Fernández H; Castro-Navarro T; Zuriguel-Pérez E; Carratala J; Juvé-Udina ME
    BMJ Open; 2021 Feb; 11(2):e041726. PubMed ID: 33597132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with hospitalizations for Covid-19 in patients with rheumatoid arthritis: data from the Reumacov Brazil registry.
    Gomides APM; de Albuquerque CP; da Mota LMH; Devidé G; Dias LH; Duarte ALBP; Giovelli RA; Karnopp TE; de Lima HD; Marinho A; de Oliveira MS; Omura F; Ranzolin A; Resende G; Ribeiro FM; Ribeiro SLE; de Carvalho Sacilotto N; Dos Santos WG; Shinjo SK; de Sousa Studart SA; Teixeira FPS; Yazbek MA; Ferreira GA; Monticielo OA; Paiva E; Pileggi GCS; Dos Reis-Neto ET; de Medeiros Pinheiro M; Marques CDL;
    Adv Rheumatol; 2022 May; 62(1):13. PubMed ID: 35505408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic.
    Serling-Boyd N; D'Silva KM; Hsu TY; Wallwork R; Fu X; Gravallese EM; Jorge AM; Zhang Y; Choi H; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2021 May; 80(5):660-666. PubMed ID: 33257496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with hospitalizations and deaths of pregnant women from Paraná due to COVID-19: a cross-sectional study.
    Bergantini LS; Ichisato SMT; Salci MA; Birolim MM; Santos MLAD; Höring CF; Rossa R; Facchini LA
    Rev Bras Epidemiol; 2024; 27():e240005. PubMed ID: 38324869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.